RNA processing events modulate final productivity of a given transgene. We have evaluated a series of RNA elements for their ability to enhance α1-antitrypsin production in mammary cells. Our results indicate the need for a case-by-case assessment of each construct design and the occurrence of gene silencing events in vivo.
Introduction
The ability to introduce genes into the germline of animals has allowed novel biotechnological applications to be developed. One of the most promising has been the generation of animal bioreactors (Houdebine, 2000) . The primary focus has been to produce novel proteins in milk, enabling repeated harvest of the protein. The basic transgene design is simple. The promoter of a gene normally active in the mammary gland during lactation, usually a milk protein gene, is linked to a cDNA or genomic fragment encoding the gene of interest. In this way, expression of genes normally active in the liver are directed to the mammary gland and hence into the milk. Attempts to improve transgene expression have largely focussed on enhancing transcription frequency within a population of founder animals , increasing transcription level within a line (James et al., 2000; Pantano et al., 2003) or through the use of large genomic fragments that are considered to contain the necessary regulatory elements (Giraldo & Montoliu, 2001) .
The production of mRNA that can be translated by the ribosome into protein is the combinatorial result of transcription and numerous RNA processing events * Author for correspondence E-mail: bruce.whitelaw@bbsrc.ac.uk (Green, 1991; Harris & Hope, 2000) . Some of the sequences regulating RNA maturation have been shown to be transferable, in that they can be incorporated into a heterologous gene construct and still function to regulate RNA processing (Huang & Yen, 1995; Liu & Mertz, 1995; Vassilakos et al., 1995; Donello et al., 1996) . In the belief that enhancing RNA processing would increase productivity (Yull et al., 1995; Houdebine, 2000) , we have now attempted to enhance transgene expression in the mammary gland through the use of RNA processing elements.
Materials and methods

Construct generation
The 566 bp PRE sequence was isolated from pGEM7.PRE (Huang & Yen, 1995) as a SphI-HindIII fragment, blunted and inserted in both orientations into BanI restricted ptgpoly (Lathe et al., 1987) , enabling subsequent excision with EcoRV and SmaI and insertion in either orientation into EcoRV restricted pBJ41 (Sola et al., 1998) , to generate pBJ41.PRE5 and pBJ41.PRE3 . The HindIII-AccI 1345 bp α1-antitrypsin cDNA fragment (Whitelaw et al., 1991) , after blunting, was inserted into the EcoRV site of pBJ41.PRE5 and pBJ41.PRE3 to generate pPRE-5 (PRE upstream of cDNA) and pPRE-3 (PRE downstream of cDNA). The 98 bp BP sequence was PCR amplified from p334 (Vassilakos et al., 1995) with SmaI and EcoRV restriction site sequences introduced into the forward (TCCCCCGGGAACTGCTAA and GGGTGAGATATCAACAACTGC) and reverse (TTTCCGATATCCATTAGAGCC and GATCCCGGG GAGCCAAGCAT) primers. Digestion with SmaI and EcoRV released the PPE sequence for insertion into the EcoRV site of pBJ41 with insertion of α1-antitrypsin cDNA as above to generate pBP-5 and pBP-3 . The 119 bp PPE sequence was PCR amplified from pTGTK1 (Wallace et al., 1991) with SmaI and EcoRV restriction site sequences introduced into the forward (TCCCCCGGGGAGGCG GCGGTG and GGGTGAGATATCGGCCGGGGA) and reverse (TCCGATATCGGGATGGCGGTC and TCCCCCGGGATGGCGGTCGAA) primers. Digestion with SmaI and EcoRV released the PPE sequence for insertion into the EcoRV site of pBJ41 with insertion of α1-antitrypsin cDNA as above to generate pPPE-5 and pPPE-3 .
Construct testing
Cell transfection and Northern blot analysis was as described previously (Donofrio et al., 1998) using an α1-antitrypsin cDNA probe generated from pUC8α1AT73 by AccI-HindIII restriction and gel purification of the resulting 1345 bp fragment containing the α1-antitrypsin cDNA, normalised to β-casein signal to correct for loading as described before (Farini & Whitelaw, 1995) . Protein levels were assessed by SDS-PAGE and Western blotting as described before (Archibald et al., 1990) and by ELISA (Wright et al., 1991) . Transgenic mice were generated as described previously with the PRE-3 isolated as a SalI-XbaI fragment. Transgenic mice were identified by PCR using internal PRE primers (TGCGTGGAACCTTTCT GGCT and TGCGCAGACCAATTTATGCCTA) and subsequently by Southern blot (data not shown).
Results and discussion
Three RNA elements were selected on their reported ability to retain function after incorporation into heterologous transcript. The 98 nucleotide (BP) sequence from the bovine bovine pre-prolactin 3 UTR is proposed to prolong translation (Vassilakos et al., 1995) . The 119 nucleotide sequence called posttranscriptional enhancer (PPE) from within the coding region of Herpes Simplex virus thymidine kinase gene enhances RNA transport (Liu & Mertz, 1995) . The 566 nucleotide sequence called post-transcriptional regulatory element (PRE) from within the coding region of Hepatitis B virus S gene enhances nuclear export of intronless transcripts (Huang & Yen, 1995; Donello et al., 1996) . The first sequence is derived from an intron-containing mammalian gene while the other two derive from viruses. The latter are predicted to function on intronless genes. Each sequence was inserted either just upstream (termed-5 ) or just downstream (termed-3 ) of the α1-antitrypsin cDNA in AAT-D (Whitelaw et al., 1991) . A fourth sequence, the constitutive transport element (CTE) of Mason Pfizer monkey virus genome (Saavedra et al., 1997) was also tested and gave comparable results to that of the BP (data not shown).
Transgenes incorporating RNA processing elements
All constructs were tested by stable transfection of mouse HC11 cells which we have previously used to evaluate splicing of β-lactoglobulin gene constructs (Donofrio et al., 1996) . In none of the hybrid constructs was an increase in steady-state mRNA observed. In one construct, PPE-3 , mRNA levels were comparable to that of the parental construct, AAT-D; in all other hybrid constructs tested mRNA levels were <50% that of AAT-D. A trend was observed in that -5 constructs gave lower mRNA levels compared to -3 constructs. We measured protein levels by Western blot and ELISA for α1-antitrypsin. The -5 constructs, all giving <40% α1-antitrypsin protein levels compared to AAT-D, were again consistently worse than their -3 counterparts (70-160% of AAT-D). Notably, PRE-3 gave the highest levels at 160% that of AAT-D. This was the only example were protein levels were increased above that of the parental construct. This appreciable increase in protein production promotes the use of this element in production systems.
In a separate experiment, we inserted these RNA elements upstream of the α1-antitrypsin genomic sequences in AAT-B (Archibald et al., 1990) . Transfection of these constructs into HC11 cells resulted in very low levels of mRNA and no detectable α1-antitrypsin protein.
We have summarised the productivity of each AAT-D based construct in Figure 1 . The presence of the RNA element sequence reduced expression at both the RNA and at the protein level resulting in similar protein:RNA ratios. The exception was PRE-3 . Based on this we generated transgenic mice with an AAT-DPRE-3 transgene. We utilised transgene co-injection rescue since this strategy is considered to facilitate transcription of cDNA-based transgenes . Basically the cDNA containing transgene is co-injected with a genomic transgene, in this case the genomic β-lactoglobulin transgene BLG.SX which has been pre-determined to be efficiently expressed (Whitelaw et al., 1992) . Milk was harvested at midlactation (11th day of lactation) female mice and α1-antitrypsin protein assayed by ELISA and Western blot. We tested seven founder G0 females and G1 females for four lines established from male founder animals in comparison to milk obtained from BAD/135 mice that have been reported to carry an active AAT-D transgene . No α1-antitrypsin protein was detected by ELISA nor Western blot. In addition, Northern blot of these mice did not detect any α1-antitrypsin mRNA in total RNA prepared from lactating mammary tissue. The presence of the PRE-3 transgene in these mice was confirmed by Southern blot and PCR analysis; founder mice may have been mosaic with regard to the presence of the transgene and this could have contributed to the lack of transgene expression in these samples.
Bearing in mind that this construct gave an appreciable increase in productivity in vitro, this result highlights the discrepancies between in vitro and in vivo expression properties of a vector (Petitclerc et al., 1995) . This contrasts with the previous demonstration of similar RNA splicing events when compared in vitro and in vivo (Donofrio et al., 1996) . One intriguing possibility is that insertion of a 566 bp viral sequence into a mammalian derived transgene is sufficient to stimulate some form of gene silencing mechanisms. This has been recognised before for reporter genes such as LacZ (Cohen-Tannoudji et al., 2000; Montoliu et al., 2000; Chevalier-Mariette et al., 2003) and other intronless sequences (Clark et al., 1997) .
Transgene silencing
To generate PRE-3 transgenic mice we utilised the transgene rescue strategy since the genomic β-lactoglobulin transgene BLG.SX facilitates expression of co-injected cDNA-based transgenes . The resulting mice, therefore, carry both the test cDNA-based transgene and the genomic β-lactoglobulin transgene. Although BLG.SX is anticipated to be expressed in all lines generated (Whitelaw et al., 1992) , in some cases the cDNA-based transgene can silence BLG.SX expression (Clark et al., 1997) . Somewhat surprisingly, when PRE-3 and BLG.SX are co-injected, even though we do not see any expression of PRE-3 transgene, we do see silencing of the BLG.SX transgene in four of the seven founders and two of the four lines analysed (Figure 2 ). Previous reports encountered a similar silencing frequency: 9 out of 11, 9 out of 11 and 6 out of 9 (Clark et al., Figure 2 . SDS-PAGE of transgenic milk. Representative SDS-PAGE of de-fatted mid-lactation milk samples stained with Coomassie-Blue. Transgenic founders are represented with a number, for example, 7; G1 animals represented by two numbers, for example, 11.4; C, purified β-lactoglobulin standard; 7H, β-lactoglobulin transgenic mouse (Opsahl et al., 2002) ; BAD, BAD/135 transgenic mouse . Note the variable presence of transgenic β-lactoglobulin protein (BLG). 1997). Southern blot confirmed that both transgenes are present in all lines analysed in this study.
We have not analysed this silencing event further but consider it likely that it is similar to that proposed previously (Clark et al., 1997) . If so and because no expression of the test transgene was detected, this may indicate that it is the transgene array that initiates the silencing event. Regardless of the silencing mechanism, we suggest that some caution is applied when incorporating this type of sequence into vectors designed for expression in animals.
Conclusion
We have analysed three RNA-processing elements in an attempt to enhance transgene expression. Initial evaluation in vitro clearly demonstrated that most construct designs reduced productivity. The exception was a construct that had the PRE sequence inserted downstream of the α1-antitrypsin cDNA were a substantial increase in the protein:RNA ratio was measured in vitro. Unfortunately, transgenic mice carrying this transgene failed to expression any α1-antitrypsin in their milk. We conclude, therefore, that although the incorporation of this type of element into in vivo expression vectors is growing in popularity (Loeb et al., 1995; Schambach et al., 2000; Barry et al., 2001; Tiscornia et al., 2003) , the amassed evidence support our conclusion that each element and construct requires to be assessed on a case-by-case basis.
